LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
US Stock MarketDetailed Quotes
PLX Protalix Biotherapeutics
- 1.830
- +0.050+2.81%
Close Dec 27 16:00 ET
- 1.830
- 0.0000.00%
Post 20:01 ET
134.75MMarket Cap-12.20P/E (TTM)
1.830High1.740Low273.08KVolume1.780Open1.780Pre Close485.41KTurnover0.50%Turnover Ratio20.33P/E (Static)73.63MShares1.85052wk High4.15P/B100.19MFloat Cap0.82152wk Low--Dividend TTM54.75MShs Float1037.500Historical High--Div YieldTTM5.06%Amplitude0.700Historical Low1.777Avg Price1Lot Size
Protalix Biotherapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 73.60%17.96M | -61.59%13.47M | -60.91%3.75M | 37.48%65.49M | 21.69%10.49M | -27.06%10.35M | 300.72%35.08M | -40.39%9.59M | 24.22%47.64M | 0.80%8.62M |
| Operating revenue | 73.60%17.96M | -61.59%13.47M | -60.91%3.75M | 37.48%65.49M | 21.69%10.49M | -27.06%10.35M | 300.72%35.08M | -40.39%9.59M | 24.22%47.64M | 0.80%8.62M |
| Cost of revenue | 71.16%8.38M | 53.81%9.46M | -15.66%2.6M | 17.30%22.98M | 269.46%8.86M | -30.83%4.89M | 50.43%6.15M | -48.87%3.09M | 19.84%19.59M | -23.86%2.4M |
| Gross profit | 75.79%9.58M | -86.11%4.02M | -82.38%1.15M | 51.58%42.51M | -73.79%1.63M | -23.31%5.45M | 519.95%28.93M | -35.30%6.5M | 27.48%28.05M | 15.16%6.22M |
| Operating expense | -23.79%5.59M | -24.23%6.45M | -33.03%6M | -21.94%32.05M | -16.87%7.25M | -28.29%7.34M | -16.53%8.51M | -24.82%8.96M | -3.30%41.06M | -21.54%8.72M |
| Selling and administrative expenses | -29.29%2.6M | -13.57%3.48M | 0.00%3.12M | 27.73%14.96M | 33.73%4.14M | 28.86%3.67M | 54.39%4.03M | -1.24%3.12M | -8.00%11.71M | -10.62%3.1M |
| Research and development costs | -18.29%3M | -33.83%2.96M | -50.62%2.89M | -41.76%17.09M | -44.77%3.1M | -50.32%3.67M | -40.96%4.48M | -33.31%5.85M | -1.29%29.35M | -26.49%5.62M |
| Operating profit | 311.50%3.99M | -111.88%-2.43M | -97.48%-4.86M | 180.37%10.46M | -125.05%-5.62M | 39.62%-1.89M | 469.68%20.42M | -31.50%-2.46M | 36.40%-13.01M | 56.27%-2.5M |
| Net non-operating interest income expense | -188.10%-148K | 120.03%155K | 125.79%123K | -36.95%-1.89M | -13.43%-811K | 138.01%168K | -507.37%-774K | -14.66%-477K | 80.58%-1.38M | 21.43%-715K |
| Non-operating interest income | -75.96%151K | -1.69%522K | 198.26%513K | 12.22%1.29M | 43.08%-37K | 218.78%628K | -34.69%531K | -14.85%172K | 185.79%1.15M | -3,150.00%-65K |
| Non-operating interest expense | -35.00%299K | -71.88%367K | -39.91%390K | 25.74%3.18M | 19.08%774K | -28.01%460K | 109.47%1.31M | 5.02%649K | -66.37%2.53M | -28.41%650K |
| Other net income (expense) | ||||||||||
| Income before tax | 323.56%3.84M | -111.56%-2.27M | -61.21%-4.73M | 159.50%8.57M | -100.19%-6.43M | 51.81%-1.72M | 468.34%19.65M | -28.43%-2.94M | 47.80%-14.4M | 51.85%-3.21M |
| Income tax | 356.39%607K | -122.40%-69K | -170.77%-138K | -52.08%254K | -172.08%-382K | 133K | 308K | 195K | 530K | 530K |
| Net income | 274.73%3.24M | -111.39%-2.2M | -46.76%-4.6M | 155.68%8.31M | -61.60%-6.04M | 48.08%-1.85M | 462.56%19.34M | -36.96%-3.13M | 45.88%-14.93M | 43.90%-3.74M |
| Net income continuous Operations | 274.73%3.24M | -111.39%-2.2M | -46.76%-4.6M | 155.68%8.31M | -61.60%-6.04M | 48.08%-1.85M | 462.56%19.34M | -36.96%-3.13M | 45.88%-14.93M | 43.90%-3.74M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 274.73%3.24M | -111.39%-2.2M | -46.76%-4.6M | 155.68%8.31M | -61.60%-6.04M | 48.08%-1.85M | 462.56%19.34M | -36.96%-3.13M | 45.88%-14.93M | 43.90%-3.74M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 274.73%3.24M | -111.39%-2.2M | -46.76%-4.6M | 155.68%8.31M | -61.60%-6.04M | 48.08%-1.85M | 462.56%19.34M | -36.96%-3.13M | 45.88%-14.93M | 43.90%-3.74M |
| Basic earnings per share | 233.33%0.04 | -110.34%-0.03 | -20.00%-0.06 | 138.71%0.12 | -42.86%-0.1 | 57.14%-0.03 | 363.64%0.29 | 0.00%-0.05 | 50.00%-0.31 | 50.00%-0.07 |
| Diluted earnings per share | 175.00%0.03 | -114.29%-0.03 | -20.00%-0.06 | 129.03%0.09 | -42.86%-0.1 | 42.86%-0.04 | 290.91%0.21 | 0.00%-0.05 | 50.00%-0.31 | 50.00%-0.07 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |